A carregar...
Reviewing the evidence for biosimilars: key insights, lessons learned and future horizons
Biologic therapies have become central to the long-term management of many chronic diseases, including inflammatory rheumatic diseases. Over recent years, the development and licensing pathways for biosimilars have become more standardized, and several biosimilars have been made available for patien...
Na minha lista:
| Publicado no: | Rheumatology (Oxford) |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5850213/ https://ncbi.nlm.nih.gov/pubmed/28903542 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/kex276 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|